Cardiovascular events like a heart attack are more likely in people with ANCA-associated vasculitis (AAV) who also have diabetes,…
Articles by Marisa Wexler, MS
Preventive, or prophylactic treatment with certain antibiotics can reduce the risk of severe infections for people with ANCA-associated vasculitis…
Measuring the number of immune T-cells in urine could be used to help identify kidney damage in people with…
Higher blood levels of the molecule pro-calcitonin (PCT) are a marker of lung infection among ANCA-associated vasculitis (AAV) patients…
Over the past year, ANCA Vasculitis News has brought you coverage of the latest developments in research related to ANCA-associated…
Hepatitis E infection can be effectively managed in people with ANCA-associated vasculitis (AAV) by pausing immunosuppressive therapy, though patients…
People with ANCA-associated vasculitis (AAV) are at an increased risk of experiencing cardiovascular problems, such as a stroke, according…
Two cases of teen boys with ANCA-associated vasculitis (AAV) that caused heart problems — a very rare manifestation of…
After approximately $3.7 billion in acquisitions, Amgen will own the rights to Tavneos (avacopan), an approved oral therapy developed by…
Measuring the blood levels of a protein called BAFF could help predict the chances of remission after induction treatment with…